|

Find HDV and Determine Its Status in Turkey

RECRUITINGSponsored by Yaşar Bayındır, MD
Actively Recruiting
SponsorYaşar Bayındır, MD
Started2024-03-11
Est. completion2025-02-01
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT06248580

Summary

The aim of these study to determine the prevalence of hepatitis Delta virus (HDV) infections and the prognosis of HDV patients in Turkey's southeast. The investigators intend to arrange training sessions for 250 family physicians in Diyarbakir, Batman, Mardin, and Sanliurfa in order to determine those goals. The investigators will talk about diagnosing hepatitis B virus (HBV), HDV, hepatitis C virus (HCV), and Human Immunodeficiency virus (HIV) infections during these events. To ensure that patients with simultaneous HDV infection are evaluated for HIV/HCV and to detect liver fibrosis with a non-invasive method.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Adults (Age≥18)
* Being HBsAg positive for at least six months
* Being a citizen of the Republic of Türkiye

Exclusion Criteria:

* There are no exclusion criteria in this study.

Conditions8

CancerChronic Hepatitis D InfectionCirrhosis, LiverFibrosis, LiverHepatocellular CarcinomaLiver CancerLiver DiseaseTransmission Vertical

Browse More Trials

Cancer trialsLiver Disease trialsLiver Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.